Furthermore, we recently reported that in patients with histologically diagnosed NAFLD/NASH, serum sdLDL-cho levels in patients with NAS ≥5 were significantly higher than those in patients with NAS≤2, and sdLDL-cho was significantly and inversely correlated with hepatic SMP30 levels [29]. Here, RGN is linked to metabolic dysfunction-associated steatohepatitis.